Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Antimicrobial resistance among animal, human and miscellaneous sources of S. Senftenberg

From: Molecular and comparative analysis of Salmonella entericaSenftenberg from humans and animals using PFGE, MLST and NARMS

Antimicrobial Breakpoint Animal
(n = 71)
Human
(n = 22)
Other
(n = 5)
Amikacin (AMI) ≥64 0 0 0
Amoxicillin/Clavulanic Acid (AUG) ≥32/16 7 (9.8%) 0 0
Ampicillin (AMP) ≥32 14 (19.7%) 0 0
Cefoxitin (FOX) ≥32 8 (11.2%) 0 0
Ceftiofur (TIO) ≥8 8 (11.2%) 0 0
Ceftriaxone (AXO) ≥4 8 (11.2%) 0 0
Chloramphenicol (CHL) ≥32 11 (15.4%) 0 0
Ciprofloxacin (CIP) ≥4 0 0 0
Gentamicin (GEN) ≥16 13 (18.3%) 0 1 (20%)
Kanamycin (KAN) ≥64 26 (36.6%) 0 1 (20%)
Nalidixic Acid (NAL) ≥32 0 0 0
Streptomycin (STR) ≥64 21 (29.5%) 0 1 (20%)
Sulfisoxazole (FIS) ≥256 37 (52.1%) 0 1 (20%)
Tetracycline (TET) ≥16 34 (47.8%) 0 1 (20%)
Trimethroprim/Sulfamethoxazole (SXT) ≥4/76 11 (15.4%) 0 0